Correlations and diagnostic tools for metabolic syndrome (MetS) and chronic obstructive pulmonary disease (COPD).
Metabolic syndrome
chronic obstructive pulmonary disease
Journal
International journal of physiology, pathophysiology and pharmacology
ISSN: 1944-8171
Titre abrégé: Int J Physiol Pathophysiol Pharmacol
Pays: United States
ID NLM: 101521074
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
07
2022
accepted:
08
12
2022
entrez:
6
2
2023
pubmed:
7
2
2023
medline:
7
2
2023
Statut:
epublish
Résumé
Regarding the importance of obesity in patients with chronic obstructive pulmonary disease (COPD), we aimed to evaluate of correlation between metabolic syndrome (MetS) and COPD. In this cross-sectional study, 96 patients with COPD were evaluated. This study was conducted in 2016-2018. The severity of COPD was determined by Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 criteria. We investigated the correlations between MetS with COPD and possible diagnostic tools. Of all COPD patients, 86.5% had MetS, and the means of waist circumference, fasting blood glucose, systolic and diastolic blood pressure, body mass index, and triglyceride in patients with MetS were significantly higher than the patients without MetS (P < 0.05). We showed that forced expiratory volume in 1 second (FEV1) with a 37% cutoff had 92.8% and 69.2% sensitivity and specificity, respectively (area of the curve: 0.51, 0.31-0.71). MetS is prevalent among COPD and FEV1 could be considered as important diagnostic tool for COPD.
Sections du résumé
BACKGROUND
BACKGROUND
Regarding the importance of obesity in patients with chronic obstructive pulmonary disease (COPD), we aimed to evaluate of correlation between metabolic syndrome (MetS) and COPD.
METHODS
METHODS
In this cross-sectional study, 96 patients with COPD were evaluated. This study was conducted in 2016-2018. The severity of COPD was determined by Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 criteria. We investigated the correlations between MetS with COPD and possible diagnostic tools.
RESULTS
RESULTS
Of all COPD patients, 86.5% had MetS, and the means of waist circumference, fasting blood glucose, systolic and diastolic blood pressure, body mass index, and triglyceride in patients with MetS were significantly higher than the patients without MetS (P < 0.05). We showed that forced expiratory volume in 1 second (FEV1) with a 37% cutoff had 92.8% and 69.2% sensitivity and specificity, respectively (area of the curve: 0.51, 0.31-0.71).
CONCLUSION
CONCLUSIONS
MetS is prevalent among COPD and FEV1 could be considered as important diagnostic tool for COPD.
Types de publication
Journal Article
Langues
eng
Pagination
311-315Informations de copyright
IJPPP Copyright © 2022.
Déclaration de conflit d'intérêts
None.
Références
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):e90-e95
pubmed: 29793992
BMJ. 2018 May 16;361:k1767
pubmed: 29769355
Expert Rev Respir Med. 2018 Dec;12(12):1061-1074
pubmed: 30296384
Int J Obes (Lond). 2017 Dec;41(12):1769-1774
pubmed: 28775377
Respir Med. 2018 Sep;142:81-85
pubmed: 30170807
Curr Environ Health Rep. 2018 Mar;5(1):110-124
pubmed: 29460222
COPD. 2017 Dec;14(6):626-634
pubmed: 29099635
Cytokine. 2018 Jun;106:95-100
pubmed: 29108795
Int J Chron Obstruct Pulmon Dis. 2019 Dec 10;14:2873-2883
pubmed: 31849460
Adv Biomed Res. 2019 Oct 31;8:62
pubmed: 31737579
Cells. 2021 Nov 01;10(11):
pubmed: 34831201
Pharmacol Ther. 2019 Jun;198:160-188
pubmed: 30822464
Ter Arkh. 2017;89(1):123-127
pubmed: 28635909
PLoS One. 2017 Oct 24;12(10):e0186708
pubmed: 29065130
Metabolites. 2020 Nov 15;10(11):
pubmed: 33203192
Chron Respir Dis. 2018 May;15(2):173-181
pubmed: 29117797
Br J Gen Pract. 2017 May;67(658):e321-e328
pubmed: 28450344
Soc Psychiatry Psychiatr Epidemiol. 2018 Nov;53(11):1149-1160
pubmed: 30182156
Medicine (Baltimore). 2017 May;96(19):e6836
pubmed: 28489768
Respir Res. 2020 May 24;21(1):126
pubmed: 32448302